Nitrosamine Uncovered Episode 3
Rethinking Risk: Closing Gaps in Nitrosamine Control What if your nitrosamine risk assessment is missing key variables? In this episode, Dr. Hemant Gandhi, Ph.D, and Dr. Arunima Pola explore the often-overlooked blind spots in nitrosamine evaluations- from analytical limitations to evolving regulatory expectations. 🔍 In this episode, you’ll learn: ▪️ Common gaps that compromise nitrosamine control strategies ▪️ Analytical and regulatory disconnects that need urgent alignment ▪️ How forward-looking companies are adapting to the complexity of nitrosamine assessment Whether you’re in QA, QC, Regulatory, or R&D, this discussion will equip you with insights to strengthen your approach.
Suggested videos

HK USP 45: Overbuilt Brilliance, Or Is It Just Overkill?
Colion Noir · 6:57

Nitrosamine Impurities-Aug 2023 NDSRIs Limit USFDA Guidance | Control of Nitrosamine Guidance Feb-21
ProfTalks · 44:52

Hype & Kompromise: The HK USP
Hop · 15:03

How to Decide the Need of Testing Nitrosamine Impurities into Pharmaceuticals?
Pharma Growth Hub · 8:35

Welcome to USP Atlanta: The Hole, The Yard, and The Rules
Larry Lawton · 26:33

Nitrosamines: Where Are We Now?
U.S. Food and Drug Administration · 23:53

United States Penitentiary - Marion, IL "1978-2005" (The ONLY Level 6 USP) - 2 Bonus Prison Shows!
Christopher Saindon · 1:59:51

Nitrosamine Impurities/NDSRIs - Current Regulatory Status
Qdot Associates · 54:41

The Legend: 5 Reasons You Still Need an HK USP 45 in 2026
FirearmFreedom · 10:41

Scientist Reveals How to BOOST NITRIC OXIDE to End Inflammation & REDUCE Blood Pressure | Dr. Bryan
Jesse Chappus and Dr Nathan Bryan Nitric Oxide · 1:56:39

I Survived USP Hazelton - Here's What the Most Violent Federal Prison Really Looks Like
Ian Bick · 1:20:46

Virus & Heart Rate, Detox Metals, Inhaled Herbs, Stubborn Metabolism, Runny Nose, Stomach Gurgling
Stephen Cabral · 21:44